Table 2.

Outcomes data for allopurinol and febuxostat.

VariablesAllopurinol, n = 102Febuxostat, n = 32p
Followup duration, weeks, median (IQR)56 (15.8–167.3)84 (28–126.8)0.607
Dose, mg/day, median (IQR)192 (131.8–217.3)41 (39.3–72.8)
Hepatotoxicity, n %36 (35.3)3 (9.4)0.005
Time to event, weeks, median (IQR)17.5 (5.5–41.5)21 (21–53.5)0.464
  • IQR: interquartile range.